🇪🇺 Molecule 129 in European Union

EMA authorised Molecule 129 on 7 January 2021

Marketing authorisation

EMA — authorised 7 January 2021

  • Marketing authorisation holder: STEMLINE THERAPEUTICS B.V.
  • Status: approved

Molecule 129 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Molecule 129 approved in European Union?

Yes. EMA authorised it on 7 January 2021.

Who is the marketing authorisation holder for Molecule 129 in European Union?

STEMLINE THERAPEUTICS B.V. holds the EU marketing authorisation.